bcl-2 oncoprotein in surgically resected nonsmall cell lung cancer: Possibly favorable prognostic factor in association with low incidence of distant metastasis

Journal of Surgical Oncology

Volumn 64, Issue 1, 1997, Pages 48-54

  Higashiyama, Masahiko ^a   Doi, Osamu ^a   Kodama, Ken ^a   Yokouchi, Hideoki ^a   Nakamori, Shoji ^a   Tateishi, Ryuhei ^a  

^a CENTER FOR ADULT DISEASES   (Japan)

Author keywords

bcl 2 oncoprotein; distant metastasis; immunohistochemistry; nonsmall cell lung cancer; prognosis; recurrence

Indexed keywords

ONCOPROTEIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER RECURRENCE; CELL TYPE; CHROMOSOME TRANSLOCATION; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; INCIDENCE; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL RATE;

EID: 0031049786     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199701)64:1<48::AID-JSO10>3.0.CO;2-S     Document Type: Article

References (38)

1. Tsujimoto Y, Croce CM: Analysis of structure, transcripts and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83;5214-5218, 1986.
2. Tsujimoto Y, Finger LR, Yunis J et al.: Cloning of chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226;1097-1099, 1984.
3. Cleary ML, Smith SD, Sklar J: Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobin transcript resulting from the t(14;18) translocation. Cell 47:19-28, 1986.
4. Korsmeyer SJ: Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80:879-886, 1992.
5. Hockenberg DM, Zutter M, Hickey W, et al.: BCL2 protein is topographically restricted in tissues characterized by apototic cell death. Proc Natl Acad Sci USA 88:6961-6965, 1991.
6. Bhargava V, Kell DL, van de Rijn M, Warnke RA: Bcl-2 immunoreactivity in breast carcinoma correlates with hormone receptor positivity. Am J Pathol 145:535-540, 1994.
7. Joensuu H, Pylkkanen L, Toikkanen S: Bcl-2 protein expression and long-term survival in breast cancer. Am J Pathol 145:1191-1198, 1994.
8. Leek RD, Kaklamanis L, Pezzella F, et al.: bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer 69:135-139, 1994.
9. Lipponen P, Pietilainen T, Kosma V-M, et al.: Apoptosis suppressing protein bcl-2 is expressed in well-differentiated breast carcinomas with favourable prognosis. J Pathol 177:49-55, 1995.
10. Hellemans P, van Dam PA, Weyler J, et al.: Prognostic value of bcl-2 expression in invasive breast cancer. Br J Cancer 72:354-360, 1995.
11. Gasparini G, Barbareschi M, Doglioni C, et al.: Expression of bcl-2 protein predicts efficacy of adjuvant treatment in operable node-negative breast cancer. Clin Cancer Res 1:189-198, 1995.
12. Sierra A, Lloveras B, Castellsague X, et al.: Bcl-2 expression is associated with lymph node metastasis in human ductal breast carcinoma. Int J Cancer 60:54-60, 1995.
13. Pilotti S, Colloni P, Rilke F, et al.: Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol 172:337-342, 1994.
14. Segers K, Ramael M, Singh SK, et al.: Immunoreactivity for bcl-2 protein in malignant mesothelioma and non-neoplastic mesothelium. Virchows Archiv 424:631-634, 1994.
15. Bronner MP, Culin C, Reed JC, Furth EE: The bcl-2 protooncogene and the gastrointestinal epithelial tumor progression model. Am J Pathol 146:20-26, 1995.
16. Bosari S, Moneghini L, Grazisni D, et al.: bcl-2 oncoprotein in colorectal hyperplastic polyps, adenomas and adenocarcinomas. Hum Pathol 26:534-540, 1995.
17. Öfner D, Riehemann K, Maier H et al.: Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: Correlation with tumour stage and patient survival. Br J Cancer 72:981-985, 1995.
18. Castle VP, Heidelberger KP, Bromberg J, et al.: Expression of the apoptosis-suppressing protein bcl-2, in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol 143:1543-1550, 1993.
19. McDonnell TJ, Troncoso P, Brisbay SM et al.: Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res 52:6940-6944, 1992.
20. Colombel M, Symmans F, Gil S, et al.: Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancers. Am J Pathol 143:390-400, 1993.
21. Segal NH, Cohen RJ, Haffejee Z, Savage N: Bcl-2 protooncogene expression in prostate cancer and its relationship to the prostatic neuroendocrine cell. Arch Pathol Lab Med 118:616-618, 1994.
22. Paraf F, Gogusev J, Chretien Y, Croz D: Expression of bcl-2 oncoprotein in renal cell tumours. J Pathol 177:247-252, 1995.
23. Pezzella F, Tse AGD, Cordell JL, et al.: Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation. Am J Pathol 137:225-232, 1990.
24. Ikegaki N, Katsumata M, Minna J, Tsujimoto Y: Expression of bcl-2 in small cell lung carcinoma cells. Cancer Res 54:6-8, 1994.
25. Ben-Ezra LM, Kornstein MJ, Grimes MM, Krystal G: Small cell carcinomas of the lung express the bcl-2 protein. Am J Pathol 145:1036-1040, 1994.
26. Higashiyama M, Doi O, Kodama K, et al.: High prevalence of bcl-2 oncoprotein expression in small cell lung cancer. Anticancer Res 15:503-505, 1995.
27. Jiang S-X, Sato Y, Kuwao S, Kameya T: Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas. J Pathol 177:135-138, 1995.
28. Pezzella F, Turley H, Kuzu I, et al.: bcl-2 protein in nonsmall-cell lung carcinoma. New Engl J Med 329:690-694, 1993.
29. Gaffney EF, O'Neill AJ, Staunton MJ: bcl-2 and prognosis in non-small-cell lung carcinoma. New Engl J Med 330:1757-1758, 1994.
30. Walker C, Robertson L, Myskow M, Dixon G: Expression of bcl-2 protein in normal and dysplastic bronchial epithelium and in lung carcinomas. Br J Cancer 72:164-169, 1995.
31. Ritter JH, Dresler CM, Wick MR: Expression of bcl-2 protein in stage TINOMO non-small cell lung carcinoma. Hum Pathol 26: 1227-1232, 1995.
32. Fontanini G, Vignati S, Bigini D, et al.: Bcl-2 protein: A prognostic factor inversely correlated to p53 in non-small cell lung cancer. Br J Cancer 71:1003-1007, 1995.
33. Mountain CF: A new international staging system for lung cancer. Chest 89:225S-233S, 1986.
34. Yunis JJ, Mayer MG, Amesen MA, et al.: bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma. New Engl J Med 320:1047-1054, 1989.
35. Leoncini L, der Vecchio MT, Megha T et al.: Correlations between apoptotic and proliferative indices in malignant non-Hodgkin's lymphomas. Am J Pathol 142:755-763, 1993.
36. Pezzella F, Jones M, Ralfkiaer E, et al.: Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma. Br J Cancer 65:87-89, 1992.
37. Piris MA, Pezella F, Martinez-Montero JC, et al.: p53 and bcl-2 expression in high-grade B-cell lymphomas: Correlation with survival time. Br J Cancer 69:337-341, 1994.
38. LeBurn DP, Warnke R, Cleary ML: Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. Am J Pathol 142:743-753, 1993.